[Comparative analysis of associated live viral vaccines against measles and mumps].
Vaccinations and revaccinations by a new Russian live associated mumps-measles vaccine and by a live trivaccine (measies-mumps-rubella)--"Priorix--were performed. We followed up 139 infants vaccinated at an age of 12-18 months, 122 children vaccinated at an age of 6-7 years and 129 persons vaccinated at an age of 18-10 years. The combined vaccines were found to be low reactogenic and high immunogenic preparations.
Pokrovskiĭ
V I
VI
Sukhinin
M V
MV
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000096:biosynthesis; D002648:Child; D006801:Humans; D007223:Infant; D008458:Measles Vaccine / Q000008:administration & dosage / Q000276:immunology*; D009108:Mumps Vaccine / Q000008:administration & dosage / Q000276:immunology*
D000914:Antibodies, Viral; D008458:Measles Vaccine; D009108:Mumps Vaccine